internet health service
internet health service with http://www.medical-mailings.com

internet health service

medical mailings

News for 14-Nov-20

Source: MedicineNet Asthma General
Mice May Be Key to Kids' Asthma Attacks at School

Source: MedicineNet Diabetes General
Standing or 'Easy' Walks May Help Type 2 Diabetics Control Blood Sugar

Source: MedicineNet Diabetes General
Insulin Prices Skyrocket, Putting Many Diabetics in a Bind

Source: MedicineNet Diabetes General
Jardiance (empagliflozin)

Source: MedicineNet Diabetes General
Chemo More Damaging to Hearts of Diabetics: Study

Source: MedicineNet Asthma General
Cured Meats Could Aggravate Asthma, Study Suggests

Source: MedicineNet Asthma General
Clean Home May Help Keep Kids' Asthma in Check

Source: MedicineNet Asthma General
Bronchodilators (Drug Class)

Source: MedicineNet Diabetes General
Daily Can of Soda Boosts Odds for Prediabetes, Study Finds

Source: MedicineNet Diabetes General
glipizide and metformin (Metaglip has been discontinued in the US)

Search the Web
internet health service
reproductive
journalism
internet health resources
workplace violence assistance
bloc obstetrical
naturopathic doctor
20910
inpatient outpatient surgery
gramercy outpatient surgery center

The Best internet health service website

All the internet health service information you need to know about is right here. Presented and researched by http://www.medical-mailings.com. We've searched the information super highway far and wide to provide you with the best internet health service site on the internet today. The links below will assist you in your efforts to find the information that you are looking for about
internet health service.

internet health service

medical mailings, email campaigns
Need information on Medical Mailings? Our links will provide you with information on all type of type of Medical Mailings for Physicians over the internet including email and snail mail. For conferencing services to go with your email campagin go to Meetings on the Net - http://www.meetingsonthenet.com
medical mailings, email campaigns

Knowing you're getting value for money is very important in buying internet health service, so by coming to this web site you can rest with the sound knowledge that you are getting the internet health service you paid for.

By buying through our recommend links you can also rest assured your internet health service will be of the highest quality. How do we know? Because when we're shopping for internet health service ourselves it's where we go.

You might wonder why we're suggesting you click on some outside links rather than stay on our internet health service site. Well it's because we've only just put this site up and haven't yet got it fully operational. Our aim is to be the best site for internet health service info on the net, and I'm sure that one day soon we'll achieve it. So please bookmark us and come back soon. Meanwhile please follow one of the links.

internet health service

medical mailings, email campaigns
Need information on Medical Mailings? Our links will provide you with information on all type of type of Medical Mailings for Physicians over the internet including email and snail mail. For conferencing services to go with your email campagin go to Meetings on the Net - http://www.meetingsonthenet.com
medical mailings, email campaigns

There are many people promoting internet health service and some are not as forthright as they should be. The information both in print and on the Internet about internet health service is widely mixed to say the least.

As you spend a few minutes with us you will see that we have a very comprehensive index of internet health service information and any question you have can be answered here. We know that your time is valuable and have made this internet health service resource site easy to navigate and of great value to our visitors.

The Cancer Research Industry

 by: Simon Mitchell

Many volunteers world-wide commit themselves to raising funds for cancer research and cancer charities. Many hundreds of thousands more work in the industry as carers, or researching, prescribing, diagnosing and manufacturing drugs. Huge companies spend fortunes on cancer research. After so long and so many billions spent what exactly has cancer research revealed?

There have been regular breakthroughs in our understanding of cancer, but little progress in its treatment. Modern research into cancer began in the 1940's and 50's when scientists isolated substances that killed cancer cells growing in a petri dish, or leukaemia cells in laboratory mice. Early successes in chemotherapy set the pace and received much media exposure, even though they only applied to 5% of cancer treatments at most.

Serving humanity by solving its major diseases has a celebrity status, there is a lot of kudos and an air of Hollywood involved in such things. Cancer research is high profile activity and every now and then a scientific treatment is discovered that gains wide recognition, such as the HPV-16 trial, but it only applies itself to the treatment of a small percentage of cancers. Mass-media hype is part of the problem of how we see cancer. Early discoveries set up an expectation that there was a cure-all treatment, a 'magic bullet' that would make its discoverer famous by curing cancer across the world. The idea stems in part from aspirin, the original bullet that magically finds its way to the pain and diminishes it.

In the 1950's and 60's huge and expensive research projects were set up to test every known substance to see if it effected cancer cells. You might remember the discovery of the Madagascar Periwinkle (Catharansus Roseus), which revealed alkaloids (vinblastine and vincristine) that are still used in chemotherapy today. Taxol, a treatment for ovarian and breast cancer originally came from the Pacific Yew tree. A treatment for testicular cancer and small-cell lung cancer called 'Etoposide' was derived from the May apple. In 'Plants Used Against Cancer' by Jonathan Hartwell over 3,000 plants are identified from medical and folklore sources for treating cancer, about half of which have been shown to have some effect on cancer cells in a test tube.

When these plants are made into synthetic drugs, single chemicals are isolated and the rest of the plant is usually thrown away. The medicinally active molecules are extracted from the plant and modified until they are chemically unique. Then the compound is patented, given a brand name and tested.

In the first phase it will generally be tested on animals, the second phase will decide dosage levels and in phase 3 it is tested on people. By the time it is approved by the Federal Drugs Authority (in U.S.A.) or the Medicines and Healthcare Products Regulation Agency (M.H.R.A.) in Britain, the development costs for a new drug can reach five hundred million dollars, which eventually has to be recouped from the consumer.

In addition to 'treatment directed' research such as finding chemicals that effect cancer cells, basic research continues apace, into differences between normal and cancerous cells. In the last 30 years this research has revealed much about our nature, but still no cure. Below are some current strands of scientific research into cancer.

antibody-guided therapy: this is the original 'magic bullet'. Cancer researchers use monoclonal antibodies to carry poisons directly to the cancer cells without harming others.

chronobiology: much of what happens in our bodies is governed by cycles, from the female monthly cycle to the cycles of brainwaves. Human health depends on interacting cycles geared to acts of perception, breathing, reproduction and renewal. Chronobiology analyses these cycles in relation to different times, such as day and night. Hormones, including stress and growth hormones, have their own cycles. For example they may be at their highest activity in the morning and quieter at night. Cancer cells seem to no longer obey the same cycle rates as normal cells.

Anti-telomerase: one part of a cell, called the telomerase, governs the life cycle of a cell and how many times it may multiply. Some cancer cells escape this control and can increase the number of times they divide, becoming 'immortal'. Researchers hope to gain control over cancer cells by stopping the action of telomerase.

Anti-angiogenesis: secondary tumours (metastasis) can persuade the cells around them to grow new blood vessels to feed the tumours, supplying oxygen and nutrients for the growing cancer. This process is called angiogenesis and research here is finding ways to stop the signals to normal cells that start the process.

Anti-adhesion molecules: Cancer cells form into clumps, unlike those in a petri dish which form into a flatter arrangement. When there are clumps of cells they seem to possess a quality that resists treatment. This strand of research looks at ways that can stop the cells clumping together, by dissolving the clumps for more effective treatment.

Anti-oncogene products: specific portions of D.N.A., called oncogenes, that have an important role in promoting cancer growth. Drugs that interfere with the production of oncogenes may be useful for the future treatment of cancer.

Gene therapy: research into the use of tumour suppressant genes is highlighted in the British National Cancer Plan as an important element. Essentially, bits of DNA are inserted to replace missing or damaged genes, possibly preventing the development of cancer in someone who might be 'high risk'.

Vaccines: very quietly the search for a general cure for cancer is being put aside in preference to finding a vaccine. The whole idea of a cure or treatment that is 'the same for everybody' breaks down in the case of the specific, chaotic conditions that cause cancer in an individual person. After billions spent on research for the holy grail of a cancer cure, the search is now on to find a vaccine.

At a recent cancer immunology conference in the US top immunologists from 21 nations attended lectures on the latest immunology topics such as:

  • cancer immunosurveillance

  • immunoediting

  • cancer antigen discovery

  • monitoring and analysing the immunological response to human cancer

  • cancer vaccine development

The Cancer Vaccine Collaborative (CVC) was launched to much excitement. It is a unique research program that should improve how cancer vaccines are developed, based on a collaboration of six New York medical centres and one in Minnesota. The aim of their research is to find out how to effectively immunise against cancer using a vaccine, using 'action research'.

Vaccines made from donor blood are proving to work for some cancers. Experiments with bone marrow transplants show there are about 40,000 different tissue types making it hard to find a match. Usually a perfect match can only be found within the patient's direct family. Incorrect matches can create a host of secondary dis-eases. Scientist are finding ways to train Killer T cells taken either from the host or a donor, to more effectively attack cancer cells. They have noticed that donor Killer T cells that are already 'primed' for a particular cancer (e.g. the donor body cells 'remember' the disease) can be highly effective. It may take many years to prove validity, reliability, safety and efficacy for this treatment. Harvesting the natural immunity of our own, or donor cells with the aid of genetic engineering may well become a big player against modern immune attacking dis-eases.

Increased screening: this type of research looks at genetically identifying individuals who might be at high risk of certain types of cancer and is partly a preparation for possible

Google

http://www.gomailings.com/
Medical Presentations | Medical Newscast | Medical Meetings On The Net | Medical Newscast | Medical Meetings On The Net

Talk On The Net   Medical Meetings On The Net   MD Meet